Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q38506135)
Watch
English
Fighting cancer drug resistance: Opportunities and challenges for mutation-specific EGFR inhibitors.
scientific article published on 12 May 2015
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
26021435
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26021435%20AND%20SRC:MED&resulttype=core&format=json
retrieved
15 February 2020
review article
1 reference
stated in
Europe PubMed Central
title
Fighting cancer drug resistance: Opportunities and challenges for mutation-specific EGFR inhibitors
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
26021435
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26021435%20AND%20SRC:MED&resulttype=core&format=json
retrieved
15 February 2020
author
Stefan Laufer
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
26021435
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26021435%20AND%20SRC:MED&resulttype=core&format=json
retrieved
15 February 2020
author name string
Michael Juchum
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
26021435
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26021435%20AND%20SRC:MED&resulttype=core&format=json
retrieved
15 February 2020
Marcel Günther
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
26021435
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26021435%20AND%20SRC:MED&resulttype=core&format=json
retrieved
15 February 2020
publication date
12 May 2015
1 reference
stated in
Europe PubMed Central
PubMed ID
26021435
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26021435%20AND%20SRC:MED&resulttype=core&format=json
retrieved
15 February 2020
published in
Drug Resistance Updates
1 reference
stated in
Europe PubMed Central
PubMed ID
26021435
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26021435%20AND%20SRC:MED&resulttype=core&format=json
retrieved
15 February 2020
volume
20
1 reference
stated in
Europe PubMed Central
PubMed ID
26021435
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26021435%20AND%20SRC:MED&resulttype=core&format=json
retrieved
15 February 2020
page(s)
12-28
1 reference
stated in
Europe PubMed Central
PubMed ID
26021435
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26021435%20AND%20SRC:MED&resulttype=core&format=json
retrieved
15 February 2020
cites work
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling
1 reference
stated in
COCI
retrieved
24 May 2022
reference URL
https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.1141478
Identifiers
DOI
10.1016/J.DRUP.2015.05.002
1 reference
stated in
Europe PubMed Central
PubMed ID
26021435
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26021435%20AND%20SRC:MED&resulttype=core&format=json
retrieved
15 February 2020
PubMed ID
26021435
1 reference
stated in
Europe PubMed Central
PubMed ID
26021435
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26021435%20AND%20SRC:MED&resulttype=core&format=json
retrieved
15 February 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
